Know Labs Founder Ron Erickson Named CEO

Know Labs, developer of non-invasive diagnostic technology, has named founder and chairman Ron Erickson as CEO of the company. He will continue to serve as the chairman as well.
 
Former CEO Phil Bosua stepped down as CEO and board member and will become a technology advisor and consultant to the company.
 
Ron Erickson is founder of Know Labs and has served with the company and its predecessors for almost 20 years. He brings 30 years of board, business development, financial and executive leadership experience from industries including therapeutics, mobile technologies and software.
 
“Thanks to Phil’s genius for invention, Know Labs’ intellectual property portfolio is second to none in the emerging field of non-invasive medical diagnostics,” Erickson told the press. “By evolving into a technology advisory and consulting role, Phil will have the freedom and flexibility to pursue his passion for new discoveries in science, software, and artificial intelligence, while participating in the value our team continues to create for shareholders.”
 
As part of his technology advisory and consulting role, Bosua will provide ad hoc technical guidance to the Know Labs product development team. Concurrently, Know Labs will transfer certain assets of its subsidiary AI Mind to Bosua, who will focus on innovation and advancements in artificial intelligence.
 
“Having established our Bio-RFIDT platform technology as a new standard for accuracy in glucose monitoring, as evidenced by our latest patent, our focus now is accelerating product development and testing while working toward the FDA clearance process for medical devices,” Erickson continued. “We anticipate our work toward this goal will accelerate in 2023, as a result of the progress made by our team, with support from our investors. We have recently expanded our team in product and clinical development functions, which are critical for our 2023 activities. I’m confident we have the right team to achieve our goals and believe Bio-RFID will transform the medical diagnostics industry and significantly improve the lives of millions of people worldwide.”
 
“When Ron and I met, back in 2018, I was intrigued by the opportunity to pursue the holy grail of the medical industry, a non-invasive blood glucose monitoring medical device,” Bosua said. “We have accomplished so much since then, and it has been an honor to lead such a great and capable team alongside Ron. The Know Labs’ foundational technology that I invented is unique and will change people’s lives, and I’m proud of that. My passion is to seek unique and challenging opportunities as I have done throughout my career. I trust that the Know Labs team has the capability to take the technology from here and deliver the first non-invasive blood glucose monitor into the market.”
 
Know Labs continues to test and refine its Bio-RFID non-invasive glucose monitoring hardware and algorithms in preparation for the FDA clearance process.